These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7839414)

  • 21. (Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation.
    Höcker B; Böhm S; Fickenscher H; Küsters U; Schnitzler P; Pohl M; John U; Kemper MJ; Fehrenbach H; Wigger M; Holder M; Schröder M; Feneberg R; Köpf-Shakib S; Tönshoff B
    Transpl Int; 2012 Jul; 25(7):723-31. PubMed ID: 22533698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group.
    Pirsch JD
    Transplantation; 1999 Oct; 68(8):1203-5. PubMed ID: 10551653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-specific cytotoxic T lymphocytes as prophylaxis for Epstein-Barr virus lymphoproliferative disease in pediatric bone marrow transplant recipients.
    Norville R; Nance D; Cheshire S
    J Pediatr Oncol Nurs; 1997 Oct; 14(4):194-201. PubMed ID: 9322393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.
    Ellis D; Jaffe R; Green M; Janosky JJ; Lombardozzi-Lane S; Shapiro R; Scantlebury V; Vivas C; Jordan ML
    Transplantation; 1999 Oct; 68(7):997-1003. PubMed ID: 10532541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lymphoproliferative syndrome induced by Epstein-Barr virus after kidney transplantation: value of genotypic analysis].
    Dussol B; Bernard O; Xerri L; Stoppa AM; Brunet P; Maraninchi D; Berland Y
    Presse Med; 1995 Jun; 24(22):1033-5. PubMed ID: 7667231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of posttransplant B-cell lymphoproliferative disorders.
    Swinnen LJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):21-5. PubMed ID: 10561014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children.
    Green M; Reyes J; Jabbour N; Yunis E; Putnam P; Todo S; Rowe D
    Transplant Proc; 1996 Oct; 28(5):2759-60. PubMed ID: 8908044
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of Posttransplant Lymphoproliferative Disorder in Pediatric Patients With a Liver Transplant.
    Aliakbarian M; Dehghani SM; Geramizadeh B; Nikeghbalian S; Kasiri K; Kazemi K; Shamsaeefar A; Bahador A; Malekhosseini SA
    Exp Clin Transplant; 2015 Oct; 13(5):426-9. PubMed ID: 25232740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
    Newell KA; Alonso EM; Kelly SM; Rubin CM; Thistlethwaite JR; Whitington PF
    J Pediatr; 1997 Jul; 131(1 Pt 1):98-104. PubMed ID: 9255199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus-associated lymphoproliferative disorders in oral cavity after heart transplantation: report of a case.
    Chang H; Wu JD; Cheng KK; Tseng HH
    J Formos Med Assoc; 1994 Apr; 93(4):332-6. PubMed ID: 7914777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible lymphoproliferative disorder with isolated lung involvement in a renal transplant patient.
    Al-Hawas FA; Abdalla AH; Fedail H; Owda AK; Mousa DH; Al-Hussaini H; Al-Sulaiman MH; Al-Khader AA
    Nephrol Dial Transplant; 1999 May; 14(5):1285-7. PubMed ID: 10344382
    [No Abstract]   [Full Text] [Related]  

  • 32. Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation.
    Imashuku S; Iwami H; Tsunamoto K; Hibi S; Todo S
    Bone Marrow Transplant; 1996 Oct; 18(4):823-4. PubMed ID: 8899207
    [No Abstract]   [Full Text] [Related]  

  • 33. Fatal case of Epstein-Barr virus-induced lymphoproliferative disorder associated with a human immunodeficiency virus infection.
    Beissner RS; Rappaport ES; Diaz JA
    Arch Pathol Lab Med; 1987 Mar; 111(3):250-3. PubMed ID: 3030225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus. A serial killer or an innocent bystander?
    Sangüeza OP
    Arch Dermatol; 1997 Sep; 133(9):1156-7. PubMed ID: 9301594
    [No Abstract]   [Full Text] [Related]  

  • 35. Issues related to development of Epstein-Barr virus vaccines.
    Spring SB; Hascall G; Gruber J
    J Natl Cancer Inst; 1996 Oct; 88(20):1436-41. PubMed ID: 8841018
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posttransplant lymphoproliferative disorders in adult kidney transplant recipients: clinical features and relationship to Epstein-Barr virus.
    Lauzurica R; Bayés B; Frías C; Hernández A; Bonet J; Fontseré N; Jimenez A; Ausina V; Romero R
    Transplant Proc; 2003 Aug; 35(5):1720-1. PubMed ID: 12962770
    [No Abstract]   [Full Text] [Related]  

  • 38. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
    Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ
    Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of lymphoproliferation caused by Epstein-Barr virus.
    Ragona G
    N Engl J Med; 1985 Jan; 312(5):316-7. PubMed ID: 2981411
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
    Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
    Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.